Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression.

Terada KY, Black M, Terada LH, Davis J, Shimizu DM.

Gynecol Oncol. 2013 Apr;129(1):188-92. doi: 10.1016/j.ygyno.2013.01.028. Epub 2013 Feb 4.

PMID:
23385149
[PubMed - indexed for MEDLINE]
2.

Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.

Grzankowski KS, Shimizu DM, Kimata C, Black M, Terada KY.

Gynecol Oncol. 2012 Sep;126(3):408-12. doi: 10.1016/j.ygyno.2012.05.019. Epub 2012 May 20.

PMID:
22617524
[PubMed - indexed for MEDLINE]
3.

Improved survival with an intact DNA mismatch repair system in endometrial cancer.

Cohn DE, Frankel WL, Resnick KE, Zanagnolo VL, Copeland LJ, Hampel H, Kelbick N, Morrison CD, Fowler JM.

Obstet Gynecol. 2006 Nov;108(5):1208-15.

PMID:
17077244
[PubMed - indexed for MEDLINE]
4.

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.

Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866.

PMID:
19898223
[PubMed - indexed for MEDLINE]
5.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
[PubMed - indexed for MEDLINE]
6.

Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer.

Resnick KE, Frankel WL, Morrison CD, Fowler JM, Copeland LJ, Stephens J, Kim KH, Cohn DE.

Gynecol Oncol. 2010 May;117(2):234-8. doi: 10.1016/j.ygyno.2009.12.028. Epub 2010 Feb 13.

PMID:
20153885
[PubMed - indexed for MEDLINE]
7.

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.

Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA.

Mod Pathol. 2010 Jun;23(6):781-9. doi: 10.1038/modpathol.2010.41. Epub 2010 Mar 19.

PMID:
20305618
[PubMed - indexed for MEDLINE]
Free Article
8.

Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.

Weber SK, Sauerwald A, Pölcher M, Braun M, Debald M, Serce NB, Kuhn W, Brunagel-Walgenbach G, Rudlowski C.

Int J Gynecol Cancer. 2012 Oct;22(8):1442-8.

PMID:
22964524
[PubMed - indexed for MEDLINE]
9.

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT.

Gynecol Oncol. 2006 Jul;102(1):92-7. Epub 2006 Jan 10.

PMID:
16406063
[PubMed - indexed for MEDLINE]
10.

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O'Malley DM, Cohn DE.

Gynecol Oncol. 2009 Sep;114(3):486-90. doi: 10.1016/j.ygyno.2009.05.026. Epub 2009 Jun 10.

PMID:
19515405
[PubMed - indexed for MEDLINE]
11.

Overexpression of MMSET in endometrial cancer: a clinicopathologic study.

Xiao M, Yang S, Chen J, Ning X, Guo L, Huang K, Sui L.

J Surg Oncol. 2013 Mar;107(4):428-32. doi: 10.1002/jso.23234. Epub 2012 Aug 6.

PMID:
22886632
[PubMed - indexed for MEDLINE]
12.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
[PubMed - indexed for MEDLINE]
13.

Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.

Tang X, Tanemura K, Ye W, Ohmi K, Tsunematsu R, Yamada T, Katsumata N, Sonoda T.

Jpn J Clin Oncol. 1998 Nov;28(11):673-8.

PMID:
9861234
[PubMed - indexed for MEDLINE]
Free Article
14.

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.

Hum Pathol. 2011 Dec;42(12):1833-40. doi: 10.1016/j.humpath.2011.02.010. Epub 2011 Jun 12.

PMID:
21664647
[PubMed - indexed for MEDLINE]
15.

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

Garg K, Leitao MM Jr, Kauff ND, Hansen J, Kosarin K, Shia J, Soslow RA.

Am J Surg Pathol. 2009 Jun;33(6):925-33. doi: 10.1097/PAS.0b013e318197a046.

PMID:
19238076
[PubMed - indexed for MEDLINE]
16.

DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.

Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR.

Gynecol Oncol. 1993 Jul;50(1):20-4.

PMID:
8349159
[PubMed - indexed for MEDLINE]
17.

The prognostic significance of vascular invasion by endometrial carcinoma.

Inoue Y, Obata K, Abe K, Ohmura G, Doh K, Yoshioka T, Hoshiai H, Noda K.

Cancer. 1996 Oct 1;78(7):1447-51.

PMID:
8839550
[PubMed - indexed for MEDLINE]
18.

[Multivariate analysis of prognostic factors in endometrial carcinoma].

Li B, Wu LY, Li SM, Zhang WH, Zhang R, Ma SK.

Ai Zheng. 2004 Sep;23(9):1085-8. Chinese.

PMID:
15363208
[PubMed - indexed for MEDLINE]
19.

Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.

Polterauer S, Khalil S, Zivanovic O, Abu-Rustum NR, Hofstetter G, Concin N, Grimm C, Reinthaller A, Barakat RR, Leitao MM Jr.

Obstet Gynecol. 2012 Jun;119(6):1210-8. doi: 10.1097/AOG.0b013e318255060c.

PMID:
22617586
[PubMed - indexed for MEDLINE]
20.

Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Steiner E, Eicher O, Sagemüller J, Schmidt M, Pilch H, Tanner B, Hengstler JG, Hofmann M, Knapstein PG.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):197-203.

PMID:
12657124
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk